A Retrospective Review of Oral N-Acetylcysteine for Habit-Driven Cutaneous Disorders.

IF 1.2 4区医学 Q3 DERMATOLOGY

Pediatric Dermatology Pub Date : 2025-05-01 Epub Date: 2025-01-16 DOI:10.1111/pde.15852

Diana H Zarowin, Amy Buros Stein, Sarah E Sheppard, James R Treat

引用次数: 0

Abstract

Oral N-acetylcysteine (NAC) has shown efficacy for debilitating habit-driven and neuropsychiatric disorders in small, mostly adult studies. We retrospectively evaluated the therapeutic use and safety of oral NAC in 93 children from the Children's Hospital of Philadelphia. This study supports the use of oral NAC for habit-driven skin, hair, and nail abnormalities in pediatric patients.

查看原文本刊更多论文

口服n -乙酰半胱氨酸治疗习惯性皮肤病的回顾性研究。

口服n -乙酰半胱氨酸（NAC）在小型成人研究中显示出对衰弱性习惯驱动和神经精神疾病的疗效。我们回顾性评估了费城儿童医院93名儿童口服NAC的治疗使用和安全性。本研究支持使用口服NAC治疗儿童患者习惯驱动的皮肤、头发和指甲异常。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

6.70%

发文量

269

审稿时长

1 months

期刊介绍： Pediatric Dermatology answers the need for new ideas and strategies for today''s pediatrician or dermatologist. As a teaching vehicle, the Journal is still unsurpassed and it will continue to present the latest on topics such as hemangiomas, atopic dermatitis, rare and unusual presentations of childhood diseases, neonatal medicine, and therapeutic advances. As important progress is made in any area involving infants and children, Pediatric Dermatology is there to publish the findings.